BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22865459)

  • 1. The microculture-kinetic (MiCK) assay: the role of a drug-induced apoptosis assay in drug development and clinical care.
    Bosserman L; Prendergast F; Herbst R; Fleisher M; Salom E; Strickland S; Raptis A; Hallquist A; Perree M; Rajurkar S; Karimi M; Rogers K; Davidson D; Willis C; Penalver M; Homesley H; Burrell M; Garrett A; Rutledge J; Chernick M; Presant CA
    Cancer Res; 2012 Aug; 72(16):3901-5. PubMed ID: 22865459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of drug-induced apoptosis assay results with oncologist treatment decisions and patient response and survival.
    Bosserman LD; Rajurkar SP; Rogers K; Davidson DC; Chernick M; Hallquist A; Malouf D; Presant CA
    Cancer; 2012 Oct; 118(19):4877-83. PubMed ID: 22354845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias.
    Kravtsov VD; Greer JP; Whitlock JA; Koury MJ
    Blood; 1998 Aug; 92(3):968-80. PubMed ID: 9680366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
    Kong D; Yamori T
    Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrate increases apoptosis induced by different antineoplastic drugs in monocytic leukemia cells.
    Ramos MG; Rabelo FL; Brumatti G; Bueno-da-Silva AE; Amarante-Mendes GP; Alvarez-Leite JI
    Chemotherapy; 2004 Nov; 50(5):221-8. PubMed ID: 15528887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated monitoring of apoptosis in suspension cell cultures.
    Kravtsov VD; Fabian I
    Lab Invest; 1996 Feb; 74(2):557-70. PubMed ID: 8780173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment.
    Gullbo J; Fryknäs M; Rickardson L; Darcy P; Hägg M; Wickström M; Hassan S; Westman G; Brnjic S; Nygren P; Linder S; Larsson R
    Biochem Pharmacol; 2011 Jul; 82(2):139-47. PubMed ID: 21531212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on antitumor drug-induced apoptosis in human cancer cells by terminal deoxynucleotidyl transferase assay].
    Tong T; Sun H; Liu L
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):111-4. PubMed ID: 10743073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro assays of chemotherapeutic sensitivity.
    Carney DN; Winkler CF
    Important Adv Oncol; 1985; ():78-103. PubMed ID: 3916747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of HUVEC apoptosis inducing proteinase from Vipera lebetina venom (VLAIP) on viability of cancer cells and on platelet aggregation.
    Samel M; Trummal K; Siigur E; Siigur J
    Toxicon; 2012 Sep; 60(4):648-55. PubMed ID: 22781133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferation and apoptosis induced by C-glycosides in human leukemia cancer cells.
    Sanhueza CA; Mayato C; García-Chicano M; Díaz-Peñate R; Dorta RL; Vázquez JT
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4223-7. PubMed ID: 16765045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
    Fridborg H; Nygren P; Dhar S; Csoka K; Kristensen J; Larsson R
    J Exp Ther Oncol; 1996 Sep; 1(5):286-95. PubMed ID: 9414416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound.
    Jiang JD; Wang Y; Roboz J; Strauchen J; Holland JF; Bekesi JG
    Cancer Res; 1998 May; 58(10):2126-33. PubMed ID: 9605756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients.
    Flick MB; O'Malley D; Rutherford T; Rodov S; Kamsteeg M; Hao XY; Schwartz P; Kacinski BM; Mor G
    J Soc Gynecol Investig; 2004 May; 11(4):252-9. PubMed ID: 15120700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research.
    Towne DL; Nicholl EE; Comess KM; Galasinski SC; Hajduk PJ; Abraham VC
    J Biomol Screen; 2012 Sep; 17(8):1005-17. PubMed ID: 22706350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
    Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
    Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferation, cell cycle arrest and apoptosis induced by a natural xanthone from Gentianopsis paludosa Ma, in human promyelocytic leukemia cell line HL-60 cells.
    Ding L; Liu B; Qi LL; Zhou QY; Hou Q; Li J; Zhang Q
    Toxicol In Vitro; 2009 Apr; 23(3):408-17. PubMed ID: 19344684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT; Sevin BU
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.